| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/21/2006 | US20060212951 ProCre nucleic acid construct comprising germline-specific promoter operatively associated with a recombinase coding sequence; facilitate production of subtle, conditional, or tissue-specific mutations in mice; genetic expression and engineering |
| 09/21/2006 | US20060212950 Inducible small rna expression constructs for targeted gene silencing |
| 09/21/2006 | US20060212949 Stable integrands |
| 09/21/2006 | US20060212948 constructing a nucleus-implanted egg produced from maternal genomes alone and having 2 haploid genome sets derived from mammal ova and is able to grow up to adulthood |
| 09/21/2006 | US20060211647 Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes; for treatment of mitochondrial diseases |
| 09/21/2006 | US20060211644 Immunostimulatory oligonucleotides |
| 09/21/2006 | US20060211641 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/21/2006 | US20060211640 Antisense modulation of farnesoid X receptor expression |
| 09/21/2006 | US20060211638 Exon 1 ss of pdgf alpha gene and utilization thereof |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211118 Induced by fermentable glucose or non-fermentable ethanol |
| 09/21/2006 | US20060211117 Methods of making minicircles |
| 09/21/2006 | US20060211116 Transposase and method of gene modification |
| 09/21/2006 | US20060211115 Methods of generating chimeric adenoviruses and uses for such chimeric aden oviruses |
| 09/21/2006 | US20060211114 Modulation of hedgehog-mediated signaling pathway |
| 09/21/2006 | US20060211113 Method and system for introducing a gene into a human stem cell |
| 09/21/2006 | US20060211102 Human lysophosphatidic acid acyltransferase gamma-1 polypeptide |
| 09/21/2006 | US20060211099 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
| 09/21/2006 | US20060211098 Cells overexpressing lipoyl-protein ligase b-gene for fermentative production of r-alpha-liponic acid |
| 09/21/2006 | US20060211095 Escherichia cell with increased secretion due to over-expression of nucleic acid encoding polypeptide of given sequence; plasmid encoding synthetase gene |
| 09/21/2006 | US20060211094 Glucose dehydrogenase beta subunit and DNA encoding the same |
| 09/21/2006 | US20060211093 Membrane scaffold proteins and embedded membrane proteins |
| 09/21/2006 | US20060211092 Membrane scaffold proteins and tethered membrane proteins |
| 09/21/2006 | US20060211091 MAGE-A3 peptides presented by HLA class II molecules |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211089 Expression of defensins in filamentous fungi |
| 09/21/2006 | US20060211086 Process for manufacture of nematode-extracted anticoagulant protein (NAP) |
| 09/21/2006 | US20060211085 disruption of the newly isolated P. pastoris AMR2 gene encoding beta 1,2-mannosyltransferase |
| 09/21/2006 | US20060211084 Simplified eukaryotic nitrate reductase |
| 09/21/2006 | US20060211081 Sec14 as an antifungal target |
| 09/21/2006 | US20060211063 Phosphokinase assay |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211051 Methods and reagents for preparing and using immunological agents specific for p-glycoprotein |
| 09/21/2006 | US20060211037 Novel mouse CXC chemokine receptor |
| 09/21/2006 | US20060211034 Nucleic acid archiving |
| 09/21/2006 | US20060211033 Novel gene |
| 09/21/2006 | US20060211032 Method of inactivating ribonucleases at high temperature |
| 09/21/2006 | US20060211031 Novel proteins and nucleic acids encoding same |
| 09/21/2006 | US20060211025 Molecular signatures of commonly fatal carcinomas |
| 09/21/2006 | US20060211021 Methods and compositions for evaluating cell function in sensory neurons |
| 09/21/2006 | US20060211017 Expression profile of prostate cancer |
| 09/21/2006 | US20060211015 detecting a difference between the levels of an expression product of a cancer associated (CA) gene in a cell in the presence and absence of an anticancer drug candidate; for carcinomas, especially lymphoma carcinomas |
| 09/21/2006 | US20060211013 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 09/21/2006 | US20060211010 Separating an intact nucleotide phosphate probe from a phosphate detectable moiety using enzymes; DNA sequencing |
| 09/21/2006 | US20060210989 Screening process for hydantoin racemases |
| 09/21/2006 | US20060210988 Method for isolating nucleic acid and, for nucleic acid isolation, kit and apparatus |
| 09/21/2006 | US20060210982 Cleavable assigned molecules and screening method using the same |
| 09/21/2006 | US20060210977 Transposon-based vectors and methods of nucleic acid integration |
| 09/21/2006 | US20060210974 Compositions and methods for preventing, treating and diagnosing diabetes |
| 09/21/2006 | US20060210969 used in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis; drug screening |
| 09/21/2006 | US20060210965 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 09/21/2006 | US20060210963 Induction of a Beta Cell Differentiation in Human Cells |
| 09/21/2006 | US20060210647 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 09/21/2006 | US20060210586 Recombination bcg vaccine |
| 09/21/2006 | US20060210585 Method for the production of hiv-1 gag virus-like particles |
| 09/21/2006 | US20060210581 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210580 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210579 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210575 Cytotoxic protein and utilization thereof |
| 09/21/2006 | US20060210571 Engineering antibodies that bind irreversibly |
| 09/21/2006 | US20060210568 Methods and compositions for cancer treatment |
| 09/21/2006 | US20060210567 Antibodies against pd-1 and uses therefor |
| 09/21/2006 | US20060210564 Novel diabody-type bispecific antibody |
| 09/21/2006 | US20060210560 TNF receptor action modulaton |
| 09/21/2006 | US20060210541 Methods for treating and preventing vascular disease |
| 09/21/2006 | US20060210538 Use of apotosis inhibiting compounds in degenerative neurological disorders |
| 09/21/2006 | US20060210537 Theileria parva DNA vaccines |
| 09/21/2006 | US20060210536 Methods and compositions for inhibiting stat signaling pathways |
| 09/21/2006 | US20060210535 Means for regulating the expression of human isoforms of ant |
| 09/21/2006 | US20060210510 Isolated polypeptide with glycosyl transferase enzymatic activity for producing dextrans with alpha (1 --> 2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan; expression vectors; genetic engineering |
| 09/21/2006 | DE102005011648A1 Verfahren zur Erhöhung der Pilzresistenz in transgenen Pflanzen durch wirtsinduzierte Unterdrückung der Genexpression in Pilzpathogenen A method for increasing the resistance to fungi in transgenic plants by host induced suppression of gene expression in fungal pathogens |
| 09/21/2006 | DE102005011579A1 Affinity marker for molecules has a hemagglutinin epitope (HA) domain with HA tag(s) and a streptavidin (Strep) domain with Strep tag(s) |
| 09/21/2006 | DE102005007480A1 New hydrophobin polypeptide not connected in normal manner with an external hydrophobin useful for coating of a glass surfaces |
| 09/21/2006 | DE102004061285A1 DNA and amino acid sequences are structured for the synthesis of bacillomycin D operon to give a variety of iturin compounds |
| 09/21/2006 | CA2842402A1 Systems and methods to perform assays for detecting or quantifying analytes within samples |
| 09/21/2006 | CA2842232A1 Systems and methods to perform assays for detecting or quantifying analytes within samples |
| 09/21/2006 | CA2742202A1 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 09/21/2006 | CA2673395A1 Human endogenous retrovirus with foamy-like properties and uses thereof |
| 09/21/2006 | CA2645003A1 Peptide stabilizer compounds and screening method |
| 09/21/2006 | CA2601525A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 09/21/2006 | CA2601243A1 Methods and composition related to in vivo imaging of gene expression |
| 09/21/2006 | CA2601209A1 Bovine cast gene snp and meat tenderness |
| 09/21/2006 | CA2600758A1 Compositions and method for storage of nucleic acid from bodily fluids |
| 09/21/2006 | CA2600690A1 Recombinant e-selectin made in insect cells |
| 09/21/2006 | CA2600568A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | CA2600565A1 Molybdenum transporter and gene thereof |
| 09/21/2006 | CA2600560A1 Method for producing plant forming nodules with high nitrogen-fixing activity |
| 09/21/2006 | CA2600505A1 Anti-mesothelin antibodies |
| 09/21/2006 | CA2600440A1 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling |
| 09/21/2006 | CA2600428A1 Maize seed with synergistically enhanced lysine content |
| 09/21/2006 | CA2600033A1 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 09/21/2006 | CA2600026A1 Recombinant expression of defensins in filamentous fungi |
| 09/21/2006 | CA2599675A1 Improvements in or relating to control of gene expression in plants |
| 09/21/2006 | CA2599640A1 Improved method of expression cloning in a host cell |
| 09/21/2006 | CA2599381A1 Corn event 3272 and methods for detection thereof |
| 09/21/2006 | CA2598234A1 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 09/21/2006 | CA2597325A1 Methods and compositions for modulating vascular integrity |
| 09/21/2006 | CA2581402A1 Novel activating agent of glucose uptake and a screening method therefor |